COMBINATION DRUG

The present invention discloses administering a trinapant-type-drug-containing pharmaceutical composition in combination with a pharmaceutical composition that contains immune cells modified to express chimeric antigen receptors or recombinant T-cell receptors. La presente invención describe la admi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TAZURU Keisuke, SONE Masayuki, SUDO Toshiki, MATSUYAMA Hironori, AKAMINE Hiroki, KOGUE Yosuke
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention discloses administering a trinapant-type-drug-containing pharmaceutical composition in combination with a pharmaceutical composition that contains immune cells modified to express chimeric antigen receptors or recombinant T-cell receptors. La presente invención describe la administración de una composición farmacéutica que contiene un fármaco de tipo tolinapant en combinación con una composición farmacéutica que contiene células inmunes modificadas que expresan receptores de antígenos quiméricos o receptores de células T recombinantes.